Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Olga Jankowska"'
Autor:
Wojciech Kraśnik, Olga Jankowska, Jacek Kurzeja, Katarzyna Piotrowicz, Hubert Piotrowicz, Agnieszka Bajkacz, Anna Rogala, Joanna Osmólska
Publikováno v:
Journal of Education, Health and Sport, Vol 75 (2024)
The recent era of rapid advancements in information technology has enabled various medical disciplines to tackle longstanding problems in novel ways. Among these, virtual reality (VR) has emerged as a promising alternative or complement to convention
Externí odkaz:
https://doaj.org/article/90a7d73790284b828d14cb3b5a6923e7
Publikováno v:
Central European Journal of Immunology, Vol 48, Iss 3, Pp 257-266 (2023)
The case report presents a patient with chronic lymphocytic leukaemia that was diagnosed in 2006 in Rotterdam, the Netherlands. In September 2010, the patient was admitted to the Department of Haematology in Poland due to progression of the underlyin
Externí odkaz:
https://doaj.org/article/56266a5e298847c59d1f6a9536b0f038
Autor:
Magdalena Bury-Kamińska, Aneta Szudy-Szczyrek, Monika Kozłowiec, Olga Jankowska-Łęcka, Aleksandra Nowaczyńska, Marek Hus
Publikováno v:
Journal of Modern Science, Vol 48, Iss 1, Pp 461-475 (2022)
Objectives The aim of the article is to study the changes in the level of cognitive and affective functioning in patients with multiple myeloma undergoing chemotherapy. Material and methods Montreal Cognitive Assessment scale (MoCA) - screening meth
Externí odkaz:
https://doaj.org/article/997aaed360dc4995a06bf4bea497dc39
Autor:
Magdalena Bury-Kamińska, Aneta Szudy-Szczyrek, Aleksandra Nowaczyńska, Olga Jankowska-Łęcka, Marek Hus, Klaudia Kot
Publikováno v:
Brain Sciences, Vol 11, Iss 9, p 1166 (2021)
The paper presents a study on the changes in cognitive functioning in patients undergoing chemotherapy with diagnosed multiple myeloma (MM). The aim of the study was to answer the following two main research questions: Does the treatment stage differ
Externí odkaz:
https://doaj.org/article/1286abf37ff142e0a9dff887e3dba64c
Autor:
Dariusz Sagan, Kamila Wojas-Krawczyk, Paweł Krawczyk, Olga Jankowska, Janusz Milanowski, Jacek Roliński
Publikováno v:
Folia Histochemica et Cytobiologica, Vol 46, Iss 4, Pp 465-470 (2009)
Therapeutic outcomes of definitively treated non-small-cell lung cancer (NSCLC) are unacceptably poor. It has been proposed that the manipulation of dendritic cells (DCs) as a "natural" vaccine adjuvant may prove to be a particularly effective way to
Externí odkaz:
https://doaj.org/article/5e68ab7d759f479481a212a7926bfa22
Autor:
Katarzyna Poniewierska-Jasak, Joanna Januszewska, Waldemar Tomczak, Magdalena Wojcierowska-Litwin, Sylwia Chocholska, Barbara Kwiatkowska-Drabik, Grazyna Swiderska-Kolacz, Sylwia Popek, Malgorzata Luterek, Marek Hus, Marcin Pasiarski, Olga Jankowska-Lecka, Iwona Surowiec, Katarzyna Cieplinska, Agata Filip, Anna Dmoszynska, Małgorzata Michalak-Wojnowska, Dorota Koczkodaj, Szymon Zmorzyński, Iwona Korszeń-Pilecka
Publikováno v:
Folia Histochemica et Cytobiologica. 55:203-211
Introduction. Significant and accessible predictive factors for bortezomib treatment in plasma cell myeloma (PCM) are still lacking. TP53 codon 72 polymorphism (P72R) results in proline (P) or arginine (R) at 72 amino acid position, which causes synt
Autor:
Olga Jankowska-Łęcka, Magdalena Bury-Kamińska, Aleksandra Nowaczyńska, Klaudia Kot, Marek Hus, Aneta Szudy-Szczyrek
Publikováno v:
Brain Sciences, Vol 11, Iss 1166, p 1166 (2021)
Brain Sciences
Volume 11
Issue 9
Brain Sciences
Volume 11
Issue 9
The paper presents a study on the changes in cognitive functioning in patients undergoing chemotherapy with diagnosed multiple myeloma (MM). The aim of the study was to answer the following two main research questions: Does the treatment stage differ
Autor:
Hartmut Döhner, Eliza Glodkowska-Mrowka, Reddy Chakkarappan Sundaram, Matthias Schunn, Michał Kiełbus, Krzysztof Giannopoulos, Stephany Corrêa, Lars Bullinger, Malgorzata Zajac, Joanna Zaleska, Jakub Czapinski, Richard F. Schlenk, Andrzej Stepulak, Grazyna Stasiak, Anna Dolnik, Konstanze Döhner, Olga Jankowska-Lecka
Publikováno v:
Oncotarget. 8:95163-95175
// Malgorzata Zajac 1, * , Anna Dolnik 2, * , Grazyna Stasiak 1 , Joanna Zaleska 1 , Michal Kielbus 3 , Jakub Czapinski 3, 4 , Matthias Schunn 2 , Stephany C. Correa 2, 5 , Eliza Glodkowska-Mrowka 2, 6, 7 , Reddy Chakkarappan Sundaram 2 , Olga Jankow
Autor:
Sylwia Chocholska, Olga Jankowska-Łęcka, Aneta Szudy-Szczyrek, Michał Mielnik, Radosław Mlak, Teresa Małecka-Massalska, Marek Hus, Michał Szczyrek, Iwona Homa-Mlak, Marcin Mazurek
Publikováno v:
British journal of haematologyReferences. 186(5)
Thalidomide is commonly used in treatment of multiple myeloma (MM). This study aimed to analyse the influence of clinical and molecular factors - single nucleotide polymorphisms (SNPs) of the CRBN gene: rs6768972 and rs1672753, on the risk of adverse
Autor:
Dariusz Jawniak, Aneta Goracy, Agnieszka Szymczyk, Elzbieta Drab-Urbanek, Małgorzata Kowal, Blanca Ibanez, Aleksandra Nowaczyńska, Marek Hus, Arkadiusz Macheta, Olga Jankowska-Lecka, Sylwia Chocholska, Monika Podhorecka
Publikováno v:
Oncotarget
// Monika Podhorecka 1 , Aneta Goracy 1 , Agnieszka Szymczyk 1 , Malgorzata Kowal 1 , Blanca Ibanez 1 , Olga Jankowska-Lecka 1 , Arkadiusz Macheta 1 , Aleksandra Nowaczynska 1 , Elzbieta Drab-Urbanek 1 , Sylwia Chocholska 1 , Dariusz Jawniak 1 and Ma